Matthew Gline
CIK 1750094 · CEO · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$622.58M
Companies
2
Total Filings
72
Lifetime Open-Market Net
-$71.73M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | CEO | 16,659,945 | $37.37 | $622.58M | -$69.51M | 30 | 2026-07-02 |
| Roivant Sciences Ltd. (ROIVW) Delisted | CEO | 1,051,732 | $2.75 | $2.89M | -$2.22M | 26 | 2023-08-29 |
Recent Filings · Page 5 of 8
72 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-28 | ROIV | Notice (144) | −12,088 | -$134.7K | EDGAR |
| 2023-08-24 | Roivant Sciences Ltd. (ROIVW) Delisted | Other (J) | −11,015 | -$119.3K | EDGAR |
| 2023-08-21 | ROIV | Notice (144) | −19,792 | -$215.1K | EDGAR |
| 2023-08-03 | Roivant Sciences Ltd. (ROIVW) Delisted | Other (J) | −11,749 | -$138.5K | EDGAR |
| 2023-07-31 | Roivant Sciences Ltd. (ROIVW) Delisted | Exer (M) | +23,149 | $0 | EDGAR |
| 2023-07-28 | ROIV | Notice (144) | −23,149 | -$250.0K | EDGAR |
| 2023-07-26 | Roivant Sciences Ltd. (ROIVW) Delisted | Other (J) | −11,146 | -$122.5K | EDGAR |
| 2023-07-21 | ROIV | Notice (144) | −19,792 | -$220.3K | EDGAR |
| 2023-06-26 | Roivant Sciences Ltd. (ROIVW) Delisted | Other (J) | −10,863 | -$108.7K | EDGAR |
| 2023-06-21 | ROIV | Notice (144) | −19,792 | -$193.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.